T86.91 Unspecified transplanted organ and tissue rejection

Name of the Condition

• Unspecified transplanted organ and tissue rejection

Summary

Unspecified transplanted organ and tissue rejection refers to the immune system's response against a transplanted organ or tissue, where the body recognizes the graft as foreign and attempts to reject it. This condition can compromise graft function and requires prompt medical attention to preserve transplant viability.

Causes

Rejection occurs when the immune system targets the transplanted organ or tissue, often due to differences in human leukocyte antigens (HLA) between the donor and recipient. Immune responses may be acute (occurring days to weeks post-transplant) or chronic (developing over months to years), driven by T-cell or antibody-mediated mechanisms.

Risk Factors

• History of prior transplant rejection episodes
• Inadequate or non-adherent immunosuppressive therapy
• Mismatched donor-recipient HLA compatibility
• Pre-existing autoimmune conditions
• Viral infections (e.g., cytomegalovirus) that activate immune responses
• Delayed or suboptimal post-transplant monitoring

Symptoms

• Fever or flu-like symptoms
• Pain or tenderness at the transplant site
• Swelling or redness around the graft
• Decreased organ function (e.g., reduced urine output, elevated liver enzymes)
• Fatigue or malaise
• Unexplained weight loss

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests (e.g., organ function panels, immune markers), and imaging studies (e.g., ultrasound, biopsy) to assess graft viability. Biopsies may confirm rejection by identifying inflammatory infiltrates or tissue damage.

Treatment Options

Treatment focuses on suppressing the immune response, often with high-dose corticosteroids, antithymocyte globulin, or adjusted immunosuppressants. In some cases, plasmapheresis or monoclonal antibodies may be used to reduce antibody-mediated rejection.

Prognosis and Follow-Up

Prognosis depends on the rejection type, timing, and organ involved. Early detection and treatment improve outcomes, but chronic rejection may lead to graft failure. Regular follow-up with organ function monitoring is essential to manage long-term risks.

Complications

• Graft failure or loss
• Increased risk of infections due to immunosuppression
• Side effects from intensive immunosuppressive therapy (e.g., nephrotoxicity)
• Chronic organ dysfunction
• Need for re-transplantation

Lifestyle & Prevention

• Strict adherence to prescribed immunosuppressive regimens
• Avoidance of infections (e.g., vaccinations, hygiene)
• Regular monitoring of organ function as directed
• Prompt reporting of symptoms to healthcare providers

When to Seek Professional Help

Seek immediate medical attention for fever, pain at the transplant site, or signs of organ dysfunction (e.g., reduced urine output, jaundice). Early intervention is critical to prevent irreversible graft damage.

Tips for Medical Coders

Code T86.91 is assigned when documentation specifies rejection of a transplanted organ or tissue without further specification. Ensure the record supports the diagnosis and excludes more detailed codes (e.g., for specific organs) when applicable. Document the type of rejection (acute/chronic) and any contributing factors to support coding accuracy.